Fluid Management History


K.V. Pshenisnov , Yu.S. Alexandrovich , V.Yu. Alexandrovich

Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia

For correspondence: Konstantin V. Pshenisnov, MD, Ph.D., associate professor of anesthesiology, intensive care and emergency pediatrics postgraduate education, Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia; e-mail: Psh_K@mail.ru

For citation: Pshenisnov KV, Alexandrovich YuS, Alexandrovich VYu. Fluid Management History. Intensive Care Herald. 2017;4:66–75. DOI:10.21320/1818-474X-2017-4-66-75

The article is devoted to the history of development of fluid management as a treatment method, special attention is paid to pioneers and founders of the modern concepts of fluid management, the evolution of various crystalloid and colloid solutions for fluid therapy is presented.

Keywords: fluid management, solutions for infusion, crystalloids, colloids

Received: 11.09.2017

Read in PDF


  1. Инфузионно-трансфузионная терапия в клинической медицине: руководство для врачей [В.В. Баландин, Г.М. Галстян, Е.С. Горобец и др.]: под ред. Б.Р. Гельфанда. М.: ООО «Медицинское информационное агентство», 2009. [Infuzionno-transfuzionnaja terapija v klinicheskoj medicine (Fluid and transfusion therapy in clinical medicine): Rukovodstvo dlja vrachej. [V.V. Balandin, G.M. Galstjan, E.S. Gorobec et al.]: ed.: R. Gelfand. Moscow: OOO “Medicinskoei nformacionnoe agentstvo”, 2009. (In Russ)]
  2. Александрович Ю.С., Гордеев В.И., Пшениснов К.В. Современные принципы инфузионной терапии в педиатрической практике. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2011; 3: 54–59. [Aleksandrovich Yu.S., Gordeev V.I., Pshenisnov K.V. Modern principles of infusion therapy in Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii. 2011; 3: 54–59. (In Russ)]
  3. Гордеев В.И. Практикум по инфузионной терапии при неотложных состояниях у детей. СПб.: ЭЛБИ-СПб, 2014. [Gordeev V.I. Praktikum po infuzionnoj terapii pri neotlozhnyh sostojanijah u detej (Workshop on fluid management at emergencies states at children). St.-Petersburg: JeLBI-SPb, 2014. (In Russ)]
  4. Dagnino J. Wren, Boyle and the origins of intravenous injections and the Royal Society of London. 2009; 111(4): 923–924.
  5. O’Shaughnessy W.B. Proposal of a new method of treating the blue epidemic cholera by the injection of highly-oxygenated salts into the venous system. 1831; 1: 366–371.
  6. O’Shaughnessy W.B. The cholera in the North of England. 1831; 1: 401–404.
  7. O’Shaughnessy W.B. Experiments on the blood in Lancet. 1831; 1: 490.
  8. O’Shaughnessy W.B. Chemical pathology of Lancet. 1832; 2: 225–232.
  9. Cosnett J.E. The origins of intravenous therapy. 1989; 1(8641): 768–771.
  10. Masson A.H.B. Latta — a pioneer in saline infusion. J. Anaesth. 1971; 43: 681–686.
  11. Baskett T.F. William O’Shaughnessy, Thomas Latta and the origins of intravenous saline. Resuscitation. 2002; 55: 231–234.
  12. Latta T.A. Relative to the treatment of cholera by the copious injection of aqueous and saline fluids into the veins. 1832; 2: 274–277.
  13. Latta T.A. Letter detailing three Lancet. 1832; 2: 370–373.
  14. Latta T.A. Saline venous injection in cases of malignant cholera performed while in the vapour-bath. Lancet. 1832; 2: 173–176.
  15. Latta T.A. Saline venous injection in cases of malignant cholera performed while in the vapour-bath. Lancet. 1832; 2: 208–209.
  16. Lewins R. Letter. Lancet. 1831; 2:
  17. MacGillivary N. Dr Thomas Latta: the father of intravenous infusion. Infect. Prev. 2009; 10: s3–6.
  18. [No author listed] The cases of cholera successfully treated by large aqueous injections. Lancet. 1832; 2: 284–286.
  19. Bartecchi C.E. Intravenous therapy: from humble beginnings through 150 years. South. Med. J. 1982; 75(1): 61–64.
  20. Millam D. A century of progress of IV Nation. Intrav. Ther. Assoc. 1981; 4: 25–27.
  21. Fye W.B. Sydney Ringer, calcium, and cardiac function. Circulation. 1984; 69(4): 849. URL: http://circ.ahajournals.org/content/69/4/849.full.pdf.
  22. Caprette D.R. An “accidental: discovery”. URL: http://www.ruf. rice.edu/~bioslabs/tools/notebook/ html.
  23. Sternbach G. Sydney Ringer: water supplied by the new river water company. Emerg. Med. 1988; 6(1): 71–74.
  24. Awad S., Allison S.P., Lobo D.N. The history of 0.9 % saline. Nutr. 2008; 27(2): 179–188.
  25. Matas R.M. A clinical report on intravenous saline infusion in the wards of the New Orleans Charity Hospital from June 1888 to June 1891. New Orleans Med. Surg. J. 1891; 19(1): 83–88.
  26. Matas R.M. The continuous intravenous “drip”. Surg. 1924; 79: 643–661.
  27. Holt L.E., Courtney A.M., Fales H.L. The chemical composition of diarrheal as compared with normal stools in infants. J. Dis. Child. 1915; 9: 213–224.
  28. Howland J., McKim Marriott W. Acidosis occurring with Am. J. Dis. Child. 1916; 11: 309–325.
  29. Gamble J.L., Ross G.S., Tisdall F.F. The metabolism of fixed base during fasting. Biol. Chem. 1923; 57: 633–695.
  30. Marriott W.M. Some phases of the pathology of nutrition in infancy. Amer. J. Dis. 1920; 20: 461.
  31. Hartmann A.F., Senn M.J.E. Studies in the metabolism of sodium r-lactate. Response of human subjects with acidosis to the intravenous injection of sodium r-lactate. Journal of clinical investigations. 1932; 11: 337–344.
  32. Darrow D.C., Yannett H. The changes in the distribution of body water accompanying increase and decrease in extracellular electrolytes. Journal of clinical 1935; 14: 266–275.
  33. Zander R. Fluid management. Melsungen: Bibliomed — Medizinische Verlagsgesellschaft mbH, 2009.
  34. Горобец Е.С. Периоперационная инфузионная терапия: модернизация подходов, спорные вопросы и новые проблемы. Вестник интенсивной терапии. 2014; 4: 30–38. [Gorobec E.S. Perioperacionnaja infuzionnaja terapija: modernizacija podhodov, spornye voprosy i novye problemi (Perioperative fluid management: modernization of approaches, controversial issues and new problems). Vestnik intensivnoj terapii. 2014; 4: 30–38. (In Russ)]
  35. Luft J.H. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed. Proc. 1966; 25:1773–1783.
  36. Chappell D., Jacob M. Role of the glycocalyx in fluidmanagement: Small things matter. Best Pract. Res. Clin. Anaesthesiol. 2014; 28(3): 227–234.
  37. Hogan J.J. The intravenous use of colloidal (gelatin) solutions in shock. 1915; 64: 721–726.
  38. Jacobson S.D., Smyth C.J. Gelatin as a substitute for plasma. Observations on its administration to human beings. Archives of Internal medicine. 1944; 74: 254–257.
  39. Tourtelotte D., Williams H.E. Acytated gelatins and their preparation. US Patent. 1958; 2:
  40. Hecht G., Weese H. Periston, ein neuer blutflüssigkeitsersatz. Münchener Medizinische Wochenschrift. 1943; 90:
  41. Grönwall A. Dextran and its use in colloidal infusion Uppsala: Almquist and Wiksell, Printers & Publishers, 1957.
  42. Kumar S. Clinical use of hydroxyethyl starch and serious adverse effects: Need for awarenessamongst the medicalfraternity. Med. J. Armed Forces India. 2014; 70(3): 209–210.
  43. Thompson W.L., Britton J.J., Walton R.P. Persistence of starch derivatives and dextran when infused after Journal of Pharmacology and Experimental Therapeutics. 1962; 136(1): 125–132.
  44. Wiedersheim M. An investigation of oxyethyl starch as a new plasma volume expanderin animals. Internatl. Pharmacodyn. 1957; 111: 353–361.
  45. Барышев Б.А. Кровезаменители. Компоненты крови: справочник для врачей. 3-е изд., перераб. и доп. СПб.: Изд-во Н-Л, 2010. [Baryshev B.A. Krovezameniteli. Komponenty krovi (Blood substitutes. Blood components): spravochnik dlja vrachej. 3rd Saint-Petersburg: Izd-vo N-L, 2010. (In Russ)]
  46. From a plasma volume expander to a drug. A practical guide for the therapeutic use of albumin. AIM Publishing, 2010.
  47. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. 1998; 317(7153): 235–240.
  48. Gibney E.M. Albumin meta-analysis. Intern Med. 2001; 135(11): 1008–1009.
  49. Finfer S., Bellomo R., Boyce N., French J., Myburgh J., Norton R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. Engl. J. Med. 2004; 350(22): 2247–2256.
  50. Vincent J.L. Relevance of albumin in modern critical care medicine. Best Res. Clin. Anaesthesiol. 2009; 23(2): 183–191.
  51. Huo X., Wang X., Kang Clinical study of volume resuscitation in children with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014; 26(4): 253–257.
  52. Martin G.S., Mangialardi R.J., Wheeler A.P., Dupont W.D., Morris J.A., Bernard G.R. Albumin and furosemide therapy in hypoproteinemic patients with acute lung Crit. Care Med. 2002; 30(10): 2175–2182.
  53. Kuper M., Gunning P., Halder S., Soni N. The short-term effect of hyperoncotic albumin, given alone or with furosemide, on oxygenation in sepsis-induced acute respiratory distress syndrome. Anaesthesia. 2007; 62(3): 259–263.
  54. Uhlig C., Silva P.L., Deckert S., Schmitt J., de Abreu M.G. Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit. Care. 2014; 18(1): 0.
  55. Müller Dittrich M.H., Brunowde Carvalho W., Lopes Lavado E. Evaluation of the “early” use of albumin in children with extensive burns: a randomized controlled Pediatr. Crit. Care Med. 2016; 17(6): e280–286.
  56. SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health, Myburgh J., Cooper D.J., Finfer S., Bellomo R., Norton R., Bishop N., Kai Lo S., Vallance Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N. Engl. J. Med. 2007; 357(9): 874–884.
  57. Finfer S. Reappraising the role of albumin for Curr. Opin. Crit. Care. 2013; 19(4): 315–320.
  58. Cooper D.J., Myburgh J., Heritier S., Finfer S., Bellomo R., Billot L., Murray L., Vallance S.; SAFE-TBI Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? Neurotrauma. 2013; 30(7): 512–518.
  59. Семенова Ж.Б., Мельников А.В., Саввина И.А., Лекманов А.У., Хачатрян В.А., Горелышев С.К. Рекомендации по лечению детей с черепно-мозговой травмой. Российский вестник детской хирургии, анестезиологии и реаниматологии. 2016; 6(2): 112–131. [Semenova Zh.B., Melnikov A.V., Savvina I.A., Lekmanov A.U., Khachatryan V.A., Gorelyshev S.K. Recommendations for treatment of children with craniocerebral trauma. Rossijskij vestnik detskoj hirurgii, anesteziologi i 2016; 6(2): 112–131. (In Russ)]
  60. Кровообращение и анестезия. Оценка и коррекция системной гемодинамики во время операции и анестезии: под ред. проф. К.М. Лебединского. СПб.: Человек, 2012. [Krovoobrashhenie i Ocenka I korrekcija sistemnoj gemodinamiki vo vremja operacii i anestezii (Circulation and anesthesia. Assessment and correction of system haemodynamics during operation and anesthesia): ed. prof. K.M. Lebedinsky. Saint-Petersburg: Chelovek, 2012. (In Russ)]